cranial irradiation and suggest that CNS prophylaxis without childhood leukemia and non-Hodgkin lymphoma (NHL) has cranial irradiation may have neurotoxic effects as well. 3, 7,8 negative effects on intelligence. We investigated the clinical Neurotoxicity of CNS prophylaxis has been evaluated by 
Methods

Introduction
Subjects
Prophylactic treatment for early eradication of occult central Childhood cancer survivors (excluding patients with brain nervous system (CNS) involvement in children with leukemia tumors and patients with CNS involvement at diagnosis) and non-Hodgkin lymphoma (NHL) has contributed signifitreated at the Sophia Children's Hospital, who were in discantly to improved survival rates. 1 Most initial treatment proease-free remission and attended grade 3-6 in primary school tocols with effective CNS prophylaxis contained cranial (corresponding with age 8-12 years), were consecutively irradiation (24 Gy or later 18 Gy) in combination with intraincluded when they visited the outpatient clinic (compliance thecal chemotherapy. During the last decade, cranial 96%). The cancer survivors were divided into three groups: irradiation has been replaced in several treatment protocols children with leukemia or NHL treated with CNS prophylaxis by intravenous high-dose methotrexate (MTX) plus intrathecal with cranial irradiation; children with leukemia or NHL chemotherapy. This replacement was based on reports that treated with CNS prophylaxis consisting of chemotherapy intellectual and neuropsychological dysfunction was observed only; and children diagnosed with solid tumors treated within survivors of childhood leukemia following CNS prophylaxis out any form of CNS prophylaxis. Characteristics of the with cranial irradiation.
2-4 Although many studies found a patients are summarized in Table 1 . decline in IQ associated with cranial irradiation, the IQ scores CNS prophylaxis of leukemia and NHL patients with cranial of these survivors were still within the normal range.
2-4 Other irradiation consisted of 25 Gy (until February 1983; n = 26) reports showed no difference in neuropsychological sequelae or 18 Gy (until October 1983; n = 4) in 13 fractions plus five after cranial irradiation as compared to CNS prophylaxis with intrathecal (i.t.) injections of methotrexate (MTX) (12.5 mg/m 2 chemotherapy only. 5, 6 These conflicting findings made it difwith a maximum of 15 mg/m 2 per dose) delivered in 3 weeks; ficult to draw definitive conclusions about the adverse role of oral prednisone was given in courses over 2 years (total cumulative dose: 1400 mg/m 2 n = 4; 9800 mg/m 2 n = 13; 21 300 mg/m 2 n = 1). High-risk ALL patients, defined as having an initial white blood cell count у50 × 10 9 /l or mediastinal (ALL: n = 27) Wilms' tumors: n = 7 (ANLL = 1) (ANLL: n = 4) Neuroblastoma: n = 5 NHL = 1 NHL: n = 5 Bone tumors: n = 4 Miscellaneous: n = 6 High-risk ALL patients n = 10 n = 5 -Mean age at diagnosis 4 yrs 1 mo 5 yrs 2 mo 5 yrs 6 mo (range) (2 yrs 0 mo-12 yrs 0 mo) (1 yr 3 mo-8 yrs 3 mo) (7 mo-10 yrs 6 mo) Mean age at evaluation 11 yrs 2 mo 9 yrs 10 mo 9 yrs 9 mo (range) (9 yrs 2 mo-13 yrs 2 mo) (8 yrs 2 mo-13 yrs 1 mo) (8 yrs 6 mo-14 yrs 1 mo) Mean time lapse since end 4 yrs 3 mo 3 yrs 2 mo 3 yrs 7 mo of treatment (range) (4 mo-6 yrs 11 mo) (1 yrs 2 mo-6 yrs 2 mo) (4 mo-8 yrs 3 mo) ALL, acute lymphoblastic leukemia; ANLL, acute non-lymphoblastic leukemia; NHL, non-Hodgkin lymphoma.
(2000 mg/m 2 ) instead of prednisone and one patient with
Assessment of learning problems
ANLL received 16 000 mg/m 2 methylprednisolone. The identification of learning problems in patients and conSince October 1983, cranial irradiation has been fully omittrols is based on the school system's assessment of the child. ted from CNS prophylaxis. CNS prophylaxis for ALL and NHL
The Netherlands has a unique system for detecting learning patients consisted of three (n = 28) or six (n = 2) courses of problems. Children who have problems in regular school are high-dose MTX (HDMTX) intravenously (2 g/m 2 ) plus i.t. MTX, presented by the school to an independent educational serfollowed by i.t. triple therapy (MTX, prednisolone, cytarabine; vice, provided by the government, for further psychological n = 23) once every 7 weeks for 1 year 12 or four courses of and educational assessment. If the service validates learning HDMTX (5 g/m 2 ) (n = 2). 13 All patients with ALL received oral problems, the child receives special tutoring at his/her regular prednisone (total cumulative dose: 1400 mg/m 2 n = 2; 2100 school. If the problems are not remediable at the regular mg/m 2 n = 2; 21 300 mg/m 2 n = 6) and/or dexamethasone school, the child is referred to a special school. Children are (total cumulative dose: 280 mg/m 2 n = 2; 1470 mg/m 2 n = 17). only transferred to these special schools after extensive Four patients with ANLL received 16 000 mg/m 2 methylpredpsychological and didactic selection procedures (including IQ nisolone and one patient with NHL received 4000 mg/m 2 testing). Before they are admitted to these schools, the severity prednisone.
of their learning problems has to be validated once again by Because the treatment protocols of leukemia and NHL a committee of educational specialists. There are different patients with and without cranial irradiation were used in contypes of special schools, each type attuned to a particular secutive time periods, patients were evaluated in different problem. For example, there are schools for children with time periods; patients treated with cranial irradiation were learning problems, mental handicaps, and emotional recruited and evaluated in 1988 and patients without cranial problems. irradiation were recruited and evaluated in 1991. This proWe classified learning problems of patients and controls cedure enabled us to control for the lapse of time since cessaccording to the Dutch system. The classification mild learnation of treatment, which is an important risk factor in the ing problems applies: (1) if children attending regular school development of neuropsychological side-effects. [3] [4] [5] In total, had learning problems reported by parent and teacher; and 112 patients were eligible. Sixteen patients were excluded as (2) if these problems were confirmed by psychological assessa result of the matching procedure controlling for gender and ment and/or the necessity of individual tutoring or special age at diagnosis. The three groups of patients were matched classes. Not included in this category were school problems for these variables, because girls and younger children are associated with emotional or behavioral difficulties as well as more at risk of neuropsychological sequelae.
3,7 Analysis of those repeating grades due to missing classes during treatment variance (ANOVA) showed no significant differences between or revalidation. groups regarding time since treatment, sex, and age at diagThe classification serious learning problems applies: if chilnosis. Age at evaluation did differ among groups (F = 9.72, df dren were not able to benefit from regular education, even 2.93 P Ͻ 0.001), but this factor has no relation to eduwith extra help, and were transferred to special schools for cational outcome.
the learning disabled. To compare the learning disabilities of children surviving Parent and teacher reports on the child's educational status cancer with healthy peers, 265 children matched for race, were obtained in a standardized way, using the Child gender, age, and social economic status (SES) were drawn Behavior Checklist and the Teacher's Report Form, respectfrom a normative sample of the general population (n = 2033; ively. 15 In these questionnaires, parents and teachers indicated see Ref. 14 for sample selection and data collection whether the child had problems in school and which type of problems. Furthermore, information was provided on the type procedures). 14 of school the child was attending. A child was classified as Discussion having learning problems, if both parents and teachers con-CNS treatment has been very successful in improving survival curred in reporting them. Since the patient cohorts were studrates of hematopoietic malignancies in childhood. CNS treatied sequentially, it is important to note that the assessment of ment is, however, associated with negative effects on intelleclearning problems according to the Dutch system did not tual functioning. We found a prevalence of 44% learning change over the study period.
problems in children treated with CNS prophylaxis. This high rate of learning problems is similar to that reported in other studies in which educational problems were detected in 33-
Statistical analysis
50% of patients receiving CNS prophylaxis. 4, 8, 11, 16, 17 However, these studies did not examine the consequences of the Differences in proportions of learning problems between different types of CNS prophylaxis. Our results show that CNS groups were tested by binomial z-tests. All reported P values prophylaxis with cranial irradiation results in an almost sixare two-tailed.
fold increase of learning problems as compared to CNS prophylaxis without cranial irradiation. This latter group had the same proportion of learning problems as healthy controls,
Results
indicating that learning problems in childhood cancer survivors is not related to CNS prophylaxis per se but to CNS treatment with cranial irradiation. The extremely high proThe total group of childhood cancer survivors treated with CNS prophylaxis had significantly more learning problems portion of learning problems (80%) in the cranially irradiated group indicates that this detrimental side-effect is difficult to than those treated without CNS prophylaxis (44 vs 20%; P Ͻ 0.001). Of the survivors who received CNS prophylaxis, 80% avoid when using cranial irradiation. In addition to the neurotoxic effects of irradiation, systemic of children with cranial irradiation had learning problems compared to 14% of children without cranial irradiation (P Ͻ treatment such as methotrexate and high-dose cytarabine may have CNS consequences as well. In all patient groups systemic 0.000). This increase concerned both mild learning problems and serious learning problems. Compared to the matched treatment with potentially neurotoxic side-effects had been used. However, our study showed, that in the two groups of control group, childhood cancer survivors with cranial irradiation had a 10-fold increase of serious learning problems children treated without cranial irradiation, no differences in learning problems in comparison with the control group were (Table 2) .
Of the 10 ALL high-risk patients treated with cranial found. Therefore, systemic treatment has no or at the most a small role in the occurrence of learning problems. In contrast, irradiation, nine showed learning problems (mild learning problems n = 3; serious learning problems n = 6). This is in our results show that cranial irradiation is the major, if not exclusive, cause of learning problems in children treated for sharp contrast with the absence of learning problems in the five high-risk patients treated with chemotherapy only.
cancer. It has been shown that CNS prophylaxis without cranial Children treated for leukemia or NHL receiving CNS prophylaxis without cranial irradiation did not show more irradiation has equivalent or even better survival rates than those with cranial irradiation. 1, 12, 18 Therefore, the dramatically learning problems than childhood cancer survivors without any form of CNS prophylaxis (14 vs 20%; NS). Furthermore, increased prevalence of learning problems in children treated for leukemia or NHL with cranial irradiation emphasizes once these patient groups did not differ from the matched control group (14 vs 17% and 20 vs 17%; NS).
again the necessity of eliminating prophylactic cranial (n = 12) (n = 2) (n = 3) (n = 35) Serious learning 23% (13-33%) 40% (23-57%) 8% (0-21%) 10% (0-20%) 4% (0-9%) 4% problems (n = 15) (n = 12) (n = 3) (n = 3) (n = 11)
Total learning problems 44% (32-56%) 80% (66-94%) 14% (3-25%) 20% (6-34%) 17% (13-21%) NA (n = 29) (n = 24) (n = 5) (n = 6) (n = 46) 
